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Studies in several species, including mouse and man, have shown that B lymphocyteS 
bear on their surface membranes a receptor (termed the Fc receptor) which specifically 
binds  heat-aggregated  or  antigen-complexed  immunoglobulin  (complexed  Ig  l)  (1-6). 
The receptor is distinct from lymphocyte surface Ig (2-4) and the C3 receptor (6), and 
appears to be a  trypsin-resistant protein or glycoprotein (4). Binding to this receptor 
is apparently not dependent on complement (2, 3, 5, 6), pH, temperature, or divalent 
cations (3). The receptor is specific for a  site on the Fc portion of the complexed im- 
munoglobulin molecule (2, 4, 5), and the integrity of this site is apparently dependent 
on intact disulfide bond(s) (4). The receptor appears to play a role in antibody-depend- 
ent lymphocyte-mediated cytotoxicity (4). 
Recent  studies in this laboratory  and elsewhere have uncovered  a  system of 
routine  lymphocyte surface alloantigens  which  are determined  by genes in  the 
Ir  region  of the  H-2 complex  (7-11,  footnote  2).  These  have  been  termed  Ia 
(/r-region  associated)  antigens  (12).  Multiple  antigenic  determinants  appear 
to be involved and  at least some of these  are shared  by strains  of mice which 
differ in 11-2 haplotype.  Ia antigens  appear  by  a  variety  of criteria  to  be  ex- 
pressed primarily on B  lymphocytes (7,  11). They can be detected serologically 
in at least three ways: (a) by sera raised via immunizations  between  congenic- 
resistant  inbred  strains  of mice  which  differ  only  in  the  Ir  region  of the  11-2 
complex  (8-11);  (b)  by  testing  of anti-11-2  antisera  on  strains  which  differ in 
tt-2 haplotype but which share  Ia antigens  (7);  and  (c) by absorbing  anti-11-2 
antisera  with  T  cells  of  the  donor  11-2 haplotype,  leaving  activity  for  B-cell 
alloantigens3  Ia  antigens  appear  to  play  a  role  as  stimulators  in  mixed 
1  Abbreviations used in this paper: Agg, heat-aggregated human Ig; BSA-PBS, 2% bovine 
serum albumin in phosphate-buffered  saline, pH 7.2 or 8.0, 0.02% Na Azide; EAC, sheep red 
blood cell--19S rabbit antisheep  red  blood cell antibody-mouse complement complexes;  FI, 
fluorescein isothiocyanate; Ig, immunoglobulin;  PBS,  phosphate-buffered  saline,  pH 7.2  or 
8.0, 0.05 M PO4 and 0.15 M NaC1; RAMIG, rabbit antimouse immunoglobulin;  Rho, tetra- 
methylrhodamine isothiocyanate. 
2 Sachs, D. H., and J. L. Cone. 1974./r-associated  mouse B-cell alloantigens:  demonstration 
of multiple Ia specificities in H-2 alloantisera following absorptions with T ceils tumors. Manu- 
script submitted for publication. 
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lymphocyte cultures  (13,  14). Isolation of Ia antigens using membrane solu- 
bilization techniques has indicated that they are proteins and/or glycoproteins 
of mol wt ~-~ 30,000  (15, 16). 
The purpose of the present experiments was  to  evaluate possible  relation- 
ships between the Fc receptor and Ia antigens. Data from these studies indi- 
cate  that  the  receptor for complexed Ig  and  alloantigens controlled by  the 
Ir region of the H-2 complex are identical or closely associated on the B-lym- 
phocyte surface membrane. 
Materials  and Methods 
A nimals.--Adult male mice of all strains were used. Strains A.SW/Sn, A/J, AKR/J, C57BL/ 
10Sn  (B10),  B10.A/SgSn,  B10.D2/nSn,  B10.BR/SgSn,  C57BL/6  (B6),  B10.A(2R),  and 
(B6A)F] were purchased from Jackson Laboratories, Bar Harbor, Maine. Strain B10.A(4R) 
was obtained from our own breeding colony established from stock kindly provided by Dr. J. 
Stimpfling,  The  McLaughlin  Institute,  Great  Falls, Mont. Mice  of  strain  A.TL  were  the 
kind gift of Dr. D. C. Shreffler, Univ. of Michigan. The genetic compositions of the H-2 com- 
plexes of these strains are listed in Table I. 
Preparation  of Cdls.--A single cell suspension from spleen or thymus was prepared and red 
blood cells and their precursors, as well as granulocytic cells, were removed by density flotation 
as described by Boyum  (17).  The lymphocyte preparation was washed three times with 2% 
bovine serum albumin in phosphate-buffered saline, 0.02% Na Azide (BSA-PBS) pH 7.2 and 
then resuspended at 20 X  106/ml in BSA-PBS pH 7.2 or 8.0 as required (see below). Prepa- 
rations contained >95% small lymphocytes by the criteria of morphology and phagocytosis 
of  1 #  polystyrene  beads, and were  >96%  viable (trypan  blue  exclusion). Cells  of  lym- 
TABLE  I 
Origin  of the H-2 Haplotypes  of the Mouse Strains  Used* 
Haplotype map of H-2 complex~t 
Strain 
K  Ir  Ss  D 
B6  b  b  b  b 
B10  b  b  b  b 
A/J  k  k  I  d  d 
B10.A  k  k  I  d  d 
B10.A(2R)  k  k  d  I  b 
BI0.A(4R)  k  klb  b  b 
(B6A)F1  k/b  k/b  d/b  d/b 
B10.D2  d  d  d  d 
B10.BR  k  k  k  k 
AKR  k  k  k  k 
A.SW  s  s  s  s 
A.TL  s  I  k  k  d 
* Adapted from the review by Shreffler and Davidfl 
Vertical lines indicate presumed crossover positions of recombinant haplotypes. 
3 Shrefi~er,  D. C., and C. S. David.  1974. The H-2 major histocompatibility complex and 
the I immune response region: genetic variation, function, and organization. Manuscript sub- 
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phomas EL4  and  RDM  4, maintained in ascites form  in  B6  and  AKR  mice respectively, 
were obtained by paracentesis and further purified as described above. 
Antisera Used  for the Detection of H-2 and la Antigens.--Immunizations  were carried out as 
previously described  (7, footnote 2).  The antisera used in this study were: B10.A anti-B10, 
B10 anti-B10.A, B10.A anti-B10.D2, B10.BR anti-B10.D2, B10.D2 anti-B10.BR, A/J anti- 
A.SW, and BN rat anti-B10.D2. Each of these antisera detected antigens controlled by the 
whole H-2 complex (including Ia antigens) when tested on the donor strain (7, footnote 2). In 
order to specifically detect Ia antigens the antisera were tested on strains which differed in H-2 
haplotype but shared Ia specificities (7), or the antisera were absorbed with T  cells of the 
donor H-2 haplotype (either thymocytes or lymphoma cells of T-cell origin), leaving only ac- 
tivity against B-cell alloantigens. 2 All antisera were decomplemented by heating at 56°C  for 
30 min and were ultracentrifuged to remove material > 10S as previously described (18) imme- 
diately before use.  An Fab preparation from B10 BR anti-B10-D2 serum  was prepared  by 
trypsin digestion of the 7S fraction according to published methods (19). This preparation was 
judged free of residual intact IgG by chromatographic size on Sephadex G-200 and by complete 
loss of cytotoxic activity. The preparation contained minimal Fc by Ouchterlony double diffu- 
sion using rabbit antimouse Fab and rabbit antimouse Fc (kindly provided by Dr. R. Asofsky, 
NIH) as developing reagents. 
Other Antisera and  Antigen-Antibody Complexes.--Purified staphylococcal  nuclease  (nu- 
clease)  and mouse antibody to nuclease purified by affinity chromatography were prepared 
using methods previously described (20, 21).  Goat antimouse Ig was prepared by immunizing 
a  single goat with  1 mg of immunoelectrophoretically pure mouse Ig in complete Freund's 
adjuvant subcutaneously three times (2 wk apart). The goat was bled 1 wk  after the last in- 
jection. Based on precipitin curves, antigen-antibody complexes were formed in antigen excess 
for each test by mixing 30 #1 of mouse antinuclease (1.8 mg/ml in normal  saline) and 4 #1 of 
nuclease (1.0 mg/ml in normal saline), and incubating for 30 min at 23°C. 
Fluorescence.-- 
Surface  Ig:  Fluorescein  isothiocyonate  (F1) and  tetramethylrhodamine  isothiocyante 
(Rho)-conjugated rabbit antimouse Ig  (heavy and light chains)  (RAMIG) were purchased 
from Cappel Laboratories, Downingtown, Pa.  (lots no. 7282 and 7184).  These antisera were 
unabsorbed and were tested for specificity by immunoelectrophoresis, Ouchterlony double diffu- 
sion, lack of reactivity with thymocytes, and inhibition of activity by purified mouse Ig. These 
antisera were routinely ultracentrifuged to remove material  >10S as described  (18)  imme- 
diately before use.  Equal amounts of lymphocytes (20 >(  106/ml in BSA-PBS pH  7.2)  and 
RAMIG (Fl or Rho)  (0.5 mg/ml in PBS 7.2)  were mixed and incubated 30 min at 4°C. The 
cells were then washed three times with BSA-PBS pH 7.2,  and wet mounts were prepared in 
the same medium. Slides were read under alternate ultraviolet and phase microscopy as pre- 
viously described (4). A minimum of 200 small lymphocytes per preparation were evaluated. 
The criterion of fluorescence positivity was  uniform punctate staining over  the entire cell 
surface. 
Aggregated Ig binding:  Previous studies in mice have shown that Ig complexes prepared 
with immunoglobulin from other mammalian species or from mice bind equally well to mouse 
B  lymphocytes  (1,  22).  Therefore,  the assay utilizing Fl-conjugated heat-aggregated human 
Ig complexes (F1-Agg) developed for humans and described in detail (4) was applied to mouse 
lymphocytes without modification. Briefly, equal amounts of Fl-Agg, or, as controls, deaggre- 
gated  Fl-conjugated  7S  human Ig  (both at  1-2  mg/ml  in  PBS  pH  8.0)  and  lymphocytes 
(20)<  106/ml in BSA-PBS pH 8.0)  were mixed and incubated for 30 min at 23°C.  The cells 
were then washed three times and wet preparations were made, all in the same medium. Mi- 
croscopy was performed as described for surface Ig. The criterion of positivity was three or 
more fluorescent complexes bound per cell. 
Inhibition studies:  For inhibition by antigen-antibody complexes, lymphocytes (25 #1 at 
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complexes which had been formed in antigen excess (see above). In control tubes lymphocytes 
were mixed with equivalent amounts of either medium, mouse antinuclease alone, or nuclease 
alone. Preparations were mixed and incubated for 30 min at 23°C. The ceils were then washed 
three times with BSA-PBS pH 8.0 and assayed for the binding of F1-Agg  as described above. 
For inhibition by antisera, lymphocytes (25/~1 at 20 X  106/ml in BSA-PBS pH 7.2) were 
combined with  100/zl  of deaggregated antisera  at various dilutions,  or, as controls, normal 
mouse serum (from the same strain as the antiserum in each test), immune antiserum nonreac- 
tive with the test lymphocytes, or medium. Preparations were mixed and incubated for 30 min 
at 4°C. The cells were then washed three times with BSA-PBS pH 7.2 or 8.0 and assayed for 
surface Ig or aggregated Ig binding as described above. It should be noted that under these 
conditions FIRAMIG detected both surface Ig and bound antibody. All antisera were used at 
dilutions which were on the plateau  of cytotoxic killing for the strain of cells being tested  (7, 
footnote 2). 
C3 Rosettes.--These were performed  according to published  methods  (23) with  reagents 
kindly provided by Dr. E. Jaffe, NIH. 
RESULTS 
Binding of Ig Complexes to Mouse Lymphocytes.--The  binding of  Fl-conju- 
gated  heat-aggregated  human  Ig  (FI-Agg)  to  mouse  spleen  lymphocytes of 
various strains is listed in Table II. In each animal tested the number of cells 
binding Ig complexes was approximately the same as the number which stained 
for surface Ig. The control experiments  using  deaggregated Fl-conjugated  7S 
human Ig were completely negative, indicating that the binding of the  F1-Agg 
was not due to either natural  human antibody against mouse or to nonspecific 
binding of human Ig by some mouse lymphocytes. As is  evident in Table  II, 
different mice,  even of the  same strain,  varied in the number of lymphocytes 
which bore surface Ig and bound Ig complexes, and both markers varied syn- 
chronously. This probably reflects normal variation  in  the  number of splenic 
lymphocytes bearing these markers. Cells which bound aggregates were heterog- 
enous in the amount bound, which is analagous to the case in humans (3). 
In order to determine  whether the aggregated human Ig was binding to the 
same sites as bind mouse antibody-antigen complexes, B10 spleen lymphocytes 
were  incubated  with  mouse  antinuclease-nuclease  complexes,  washed  thor- 
oughly,  and  assayed for the  binding  of  Fl-Agg. The lymphocytes which  had 
been  incubated  with  mouse  antibody-antigen  complexes  were  almost  com- 
pletely  inhibited  in  their  ability  to  bind  F1-Agg  (4.5 %  positive  vs.  48.5 % 
positive for lymphocytes incubated in medium alone).  In contrast,  cells incu- 
bated with antigen or antibody alone were unaffected (49.0 %  and 46.5 % posi- 
tive, respectively). Thus it appeared that heat-aggregated human Ig complexes 
bind to the same sites which bind mouse antibody-antigen complexes. Previous 
studies  have shown that  the  binding of Ig complexes requires  the  Fc portion 
of the Ig molecule (2, 4, 5, 22) and the site is termed the Fc receptor. 
The above results  suggested that the Ig complexes were binding to B  cells. 
To further evaluate  this  system,  B10 thymocytes were tested  for their ability 
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TABLE  II 
Binding of Ig Complexes to Mouse Spleen Lymphocytes 
Strain  Animal no.  Surface Ig  Aggregated Ig  binding* 
% Positive 
B6  1  42.5  38.5 
2  40.7  41.3 
B10  1  42.0  42.5 
2  47.5  46.0 
B 10.A  1  48.0  46.0 
2  38.0  39.0 
B10.A(2R)  1  46.0  44.5 
2  51.0  48.5 
B10.A(4R)  1  54.0  56.0 
B 10.D2  1  42.5  44.5 
2  40.0  38.5 
B10.BR  1  47.5  51.5 
2  44.5  42.0 
(B6A)F1  t  57.0  58.0 
A/J  1  48.0  49.5 
A.TL  1  53.0  52.5 
2  47.0  46.0 
A.SW  1  49.0  46.0 
2  40.5  42.5 
* Control  experiments with  deaggregated Fl-conjugated  7S  human  Ig always showed 
<0.5% positive cells. 
RhoRAMIG  and  F1-Agg.  Less  than  2%  of  thymocytes  bound  aggregates 
(compared  with  53.0%  in  the  spleen  of  the  same  animal),  and  the  surface 
Ig-bearing  and  aggregate-binding  lymphocyte  populations  in  mouse  spleen 
were essentially overlapping (49.0% showed both markers, 4.0%  only surface 
Ig, and  2.0%  only aggregated Ig binding).  Further,  various modifications in 
the assay were made in an attempt to demonstrate binding  to T  cells. These 
included  preincubation  and  washing  of lymphocytes at  37°C  before  testing, 
and  incubation  of cells  and  Ig complexes at  different  temperatures  (4  °,  23 °, 
and 37°C), different pH's (7.2  and 8.0), and in different media (2 %  BSA-PBS 
and  Delbeco's  PBS  supplemented  with  5%  deaggregated  fetal  calf  serum). 
Binding  of  Ig complexes to  thymocytes or  thymus-derived  (non-Ig bearing) 
spleen lymphocytes could not be demonstrated under any of these conditions. 
Thus,  the heat-aggregated human Ig complexes appeared to be binding  only 
to B lymphocytes. 
Inhibition  of Binding  of Complexed Ig to B  Lymphocytes by Anti-H-2 Anti- 
sera.--Antisera  raised between  strains  of completely different H-2  haplotype 
contain  antibodies  against  antigenic  specificities  determined  by  any  of  the 
regions of the H-2 complex (including  Ia antigens)  when  tested on the strain 
against which the antiserum was raised3 Therefore, as a first test of a possible 784  THE  FC RECEPTOR  AND  Ia  ALLOANTIGENS 
relationship between Ia alloantigens and the Fc receptor, mouse spleen lympho- 
cytes  of various  strains  were  incubated  with  anti-H-2  antisera,  washed,  and 
assayed for their ability  to bind aggregated Ig complexes. As shown in Table 
III,  lymphocytes which  were  pretreated  with  these  antisera  were  markedly 
inhibited  in their ability  to bind Ig complexes. Also shown are control experi- 
ments  which indicated:  (a)  that  normal  mouse sera  from the  same strains  as 
those which produced the antisera caused no such inhibition,  (b)  that no  inhi- 
bition  was  caused by immune  mouse  serum  tested  on lymphocytes from  the 
same strain  which produced the antiserum,  and  (c)  that  antibody was  indeed 
bound  to the  target  lymphocytes as indicated  by fluorescence of T  cells with 
TABLE III 
Inhibition  by Anti-H-2 Antisera of the Binding  of Ig Complexes to Mouse B Lymphocytes 
Aggregated  Strain  Serum  Surface Ig  Ig binding 
% Positive 
B6  Normal B 10.A  43.0  42.0 
B 10.A anti-B 10  91.0  11.5 
B10  Normal B10.A  52.5  52.0 
B10 anti-B 10.A  53.0  51.5 
B10.A anti-B 10  96.0  6.5 
B10.A  Normal B10  49.5  47.0 
B10 anti-B 10.A  >99.5  7.5 
B 10.D2  Normal B 10.A  48.5  48.0 
B10.A anti-B 10.D2  91.5  9.5 
Normal B10.BR  55.0  54.0 
B10.BR anti-B10.D2  >99.5  6.0 
B10.BR  Normal B10.D2  53.0  51.0 
B10.D2 anti-B10.BR  99.5  5.5 
A.SW  Normal A/J  48.0  48.5 
A/J anti-A.SW  > 99.5  8.0 
F1RAMIG and increased intensity of fluorescence on B cells resulting from the 
detection of both surface Ig and bound antibody. Further, since all of the anti- 
H-2 antisera were raised between congenic-resistant strains which only differed 
at  H-2,  antibodies  against  non-//-2 antigens  could not  have been  responsible 
for the inhibition.  It should be noted that while inhibition was never complete, 
the residual positive cells bound very few aggregates. Since little is known about 
the relative affinities of binding of the antibodies and of Ig complexes, it seems 
possible  that some aggregates were able  to displace antibody and  bind  to the 
lymphocyte.  Nevertheless,  the  possibility  that  some  complexes  were  binding 
to sites not coated by the antisera could not be ruled out. 
A  series of experiments  was performed  to evaluate  the specificity of inhibi- 
tion of Ig complex binding by anti-H-2 antisera. One possible artifact appeared 
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and then bind to the Fc receptor via the Fc of the complexed antibody, result- 
ing in inhibition  of aggregate binding.  To  investigate  this  possibility  a  Fab 
preparation from B10.BR anti-B10.D2 antiserum was prepared and tested for 
ability  to inhibit  aggregated Ig binding  (Table  IV). As seen  in  Exp.  A,  the 
Fab  preparation  inhibited  the  binding  of  aggregates  to  B  cells,  but  not  as 
effectively as the whole antiserum from which it was made. A possible inter- 
pretation of this  result  was that  the Fab,  being univalent,  bound less  avidly 
to  the  lymphocytes. This  possibility  was  supported  by the  observation  that 
the  Fab-coated cells  stained  with  F1RAMIG were  less  fluorescent,  quantita- 
tively  and  qualitatively,  than  the  cells  coated  with  the  whole  antiserum, 
despite the fact that the concentrations had been adjusted to be equivalent in 
TABLE IV 
Inhibition  by Anti-H-2  Fab of Ig Complex Binding to Mouse B  Lymphocytes 
Aggregated  Exp.  Strain  Serum  Surface Ig  Ig Binding 
A 
B* 
% Positive 
B10.D2  Normal B10.BR  56.5  55.0 
B 10.BR anti-B10.D2  >99.5  6.0 
Fab (B10.BR anti-Bl0.D2  91.0  18.5 
B10.D2  Normal B10.BR  54.5  53.5 
B10.BR anti-Bl0.D2  99.5  5.5 
Fab (B10.BR anti-B10.D2)  --  9.5 
B10.BR  Normal B10.BR  55.5  53.5 
Fab (B10.BR anti-B10.D2)  --  52.0 
* In experiment B, cells incubated with B10.BR anti-B10.D2 Fab were not washed before 
the addition of Fl-Agg.  Volumes of incubations  with F1-Agg  in other portions of experiment B 
were adjusted so as to be equivalent. Cells incubated with B10.BR anti-B10.D2 Fab and not 
washed could not be incubated with FIRAMIG due  to cross-reactions. Reasons for  these 
modifications are detailed in the text. 
the number of combining sites.  Therefore, a second experiment was performed 
in which cells incubated with anti-H-2 Fab were not washed before incubation 
with  the  aggregates  (Exp.  B).  Under  these  conditions  the  Fab  preparation 
produced inhibition  nearly equal  to that of the whole antiserum.  The control 
(Fab  plus  cells  with  which  the  antibodies  did  not  react)  indicated  that  this 
increased inhibition was specific  and not due either to a  reaction between Fab 
fragments and  F1-Agg or to  residual  Fc in  the  Fab preparation.  Thus,  it ap- 
peared  that shedding of complexes was not the explanation for the inhibition 
of Ig complex binding to B cells produced by anti-H-2 antisera. 
In order to determine whether other antisera bound to B lymphocytes could 
inhibit  Ig complex  binding,  lymphocytes were  incubated  with  unconjugated 
goat antimouse Ig, washed, and tested for binding of Ig complexes (Table V). 
No inhibition  of Ig complex binding was produced by the antimouse Ig anti- 
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TABLE V 
Failure of Antimouse Ig to Inhibit Binding of Ig Complexes to Mouse B Lymphocytes* 
Antiserum  Surface Ig  Ig complex binding 
% Positive 
Normal mouse serum  43.0  42.0 
Anti-H-2  97.0  8.0 
Unconjugated goat antimouse Ig  7.5:~  40.5 
* Strain B6 was used. The normal serum was B10.A and the anti-H-2 antiserum B10.A 
anti-B10. There was no cross-reaction between the antimouse Ig and  the Fl-Agg as assessed 
by Ouchterlony double diffusion. 
~/Positive cells were extremely faint (i.e. +). 
tion of FIRAMIG fluorescence) and that the binding of aggregates to the same 
cells could be inhibited by the appropriate anti-H-2 antiserum. Similar results 
were obtained with antisera specific for antigens determined by the K  and D 
regions of the//-2 complex (These results will  be detailed below). These data 
provided  further evidence for the  specificity of the  inhibition  of Ig complex 
binding by some antibodies in anti-H-2 sera. 
As another criterion of specificity it seemed important to determine whether 
the anti-//-2 antisera would inhibit detection of other receptors on B lympho- 
cytes  (i.e.  nonspecific  steric  inhibition).  This  possibility  was  evaluated  with 
two separate experiments. In the first experiment, lymphocytes were incubated 
with anti-H-2 antisera, washed, and evaluated for EAC binding. In the second 
experiment,  B10.D2  lymphocytes were  incubated  with  BN  rat  anti-B10.D2 
antiserum, washed, and evaluated for surface Ig. A rat antiserum was required 
in  order  to  allow  detection  of lymphocyte surface  Ig despite  the presence of 
bound antibody.  Such  rat antisera have previously been shown to detect 11-2 
and  Ia specificities  (7).  Also,  the  reagents  in  this  experiment  (BN  rat  anti- 
B10.D2  and  FIRAMIG) were exhaustively absorbed with insoluble mouse Ig 
and rat Ig respectively, in order to prevent cross-reactions. The results (Tables 
VI and VII) showed that no inhibition of EAC binding or surface Ig staining 
was produced by antisera which caused marked inhibition of Ig complex bind- 
ing.  Thus,  no nonspecific steric inhibition  could be detected  in either system. 
The results presented in this section indicated that some antibodies in anti-//-2 
antisera inhibited  the  binding  of aggregated Ig complexes to the  Fc receptor 
of mouse B lymphocytes, and this inhibition appeared to be specific by several 
criteria. 
Inhibition of Binding of Complexed Ig to B  Lymphocytes by Antisera Specific 
for Ia Alloantigens.--In  order to determine whether the inhibition of Ig com- 
plex binding produced  by anti-//-2 antisera was due  to antibodies against  Ia 
alloantigens contained in those sera, lymphocytes were incubated with antisera 
specific for Ia antigens,  washed,  and  assayed for Ig complex binding  (Table 
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TABLE VI 
Failure of Anti-H-2  Antiserum  to  Inhibit  the Binding  of EAC to Mouse  B  Lymphocytes* 
Aggregated Ig  EAC binding  Antiserum  Surface Ig  binding 
% Positive 
Medium  51.0  49.0  38.5 
Normal mouse serum  50.5  47.5  40.0 
Anti-H-g  89.0  13.5  39.0 
* Mouse strain B10 was used. The normal serum was B10.A and the anti-H-2 antiserum 
was B10.A anti-B10. 
TABLE VII 
Failure of A nti-H-2 Antiserum to Inhibit Detection of Surface Ig on Mouse B Lymphocytes* 
Antiserum  Surface Ig  Aggregated Ig binding 
% Positive 
Medium  46.0  47.0 
Normal BN rat serum  46.5  47.5 
BN rat anti-B10.D2  48.0  5.5 
* Mouse strain B10,D2 was used. Reasons  for using rat antiserum and other details are pre- 
sented in the text, 
TABLE VIII 
Inhibition  by Anti-la Antisera of Binding of rig Complexes  to Mouse B  Lymphocytes 
Aggregated  Exp.  Strain  Antiserum  Surface Ig  Ig binding 
% Positite 
1  B6  Normal B10.A  43.0  42.0 
BI0.A anti-B 10.D2  44.5  13.0 
2  B 10  Normal B 10.A  53.0  53.5 
B10.A anti-B 10.D2  53.5  9.5 
3  B10.D2  Normal B10.A  48.5  48.0 
B 10.A anti-B 10  48.0  12.5 
4  B6  Normal B10.A  44.0  42.5 
B 10.A anti-B 10 absorbed (EL4)  45.5  13.5 
5  B10  Normal B10.A  56.0  54.5 
B 10.A anti-B 10 absorbed (EL4)  55.5  9.0 
6  B10  Normal B10.A  46.5  47.0 
B 10.A anti-B 10 absorbed (B 10  46.0  6.5 
thymoeytes) 
7  B10.BR  Normal B10.D2  48.5  46.5 
B10.D2 anti-B10.BR absorbed (RDM4)  48.0  9.5 
8  A.SW  Normal B10.A  40.5  42.5 
B 10.A anti-]] 10 absorbed (EL4)  39.5  9.5 788  THE  Fc  RECEPTOR  AND  Ia  ALLOANTIGENS 
against strains which differed at H-2 but shared Ia specificities (Exp. 1-3)  (7), 
by absorbing  anti-H-2 antisera  with  T  cells  from  the  donor strains  leaving 
specificity for B-cell alloantigens (Exp. 4-7),  2 or by a  combination of the two 
methods (Exp. 8). Anti-Ia antisera produced marked inhibition of Ig complex 
binding  in  every experiment.  Controls indicated  that:  (a)  the  antisera  were 
specific for B-cell alloantigens in that no appreciable increase in the percentage 
of cells staining with the F1RAMIG was observed following pretreatment with 
anti-Ia antibodies (compare to results obtained when detecting antigens of the 
whole H-2 complex in Table III), and (b) normal mouse serum from the same 
strains as produced the antisera caused no such inhibition. Further, it should be 
noted  that  these  anti-Ia  specificities  are  components  of  the  same  anti-H-2 
antisera for which a number of specificity controls were described (see above). 
Two preparations of the same antiserum, one absorbed with a T-cell lymphoma 
and the other with normal thymocytes, produced equivalent inhibition (Exp. 
5 and 6). The inhibition of Ig complex binding produced by antisera against 
the whole H-2 complex (Table III) and antisera specific for Ia antigens (Table 
VIII)  appeared to be equivalent. This was further supported by experiments 
in which an antiserum against  the whole H-2  complex (B10.A anti-B10)  and 
two antisera specific for Ia antigens,  one by absorption  (B10.A anti-B10 ab- 
sorbed  with  EL4),  and  one  by  cross-reactivity  (BI0.A  anti-B10.D2),  when 
serially diluted and tested on the same lymphocytes (from a single B10 spleen), 
showed identical titers. Thus, antibodies contained within antisera against the 
whole H-2 complex but specific for Ia alloantigens produced inhibition of bind- 
ing  of  Ig  complexes to  the  Fc  receptor of  B  lymphocytes.  However,  these 
experiments did not  rule out  the possibility that  antibodies against  antigens 
determined by the K  or D  regions of the H-2 complex could also produce such 
inhibition. 
Failure of Antisera Against  the K  and D Regions of the H-2 Complex to In- 
hibit Binding  of Ig Complexes to Mouse Lymphocytes.--Antiserum-strain  com- 
binations were selected such that specificity for antigens determined by the K 
or D  regions was obtained (refer to Table I). To examine D  region specificities 
a  B10.A  anti-B10  antiserum  was  tested on  B10.A(2R)  and  B10.A(4R)  cells, 
and to examine K  region specificities an A/J anti-A.SW antiserum was tested 
on A.TL cells.  The results, presented in Table IX, indicate that no inhibition 
was produced by antibodies directed only against the K  or D  region specifici- 
ties. Controls indicated that the K or D  region specific antibodies had bound to 
the test cells as shown by FIRAMIG staining of T  cells and increased intensity 
of fluorescence on B cells resulting from the detection of both surface Ig and 
bound  antibody.  Further,  cytotoxic  testing  of  these  combinations  revealed 
killing  of nearly all  lymphocytes (both  B  and  T).  4 Other controls indicated 
that both the antisera and lymphocytes used in these experiments could inhibit 
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TABLE IX 
Failure of Antisera Against Antigens Determined by the K or D Regions of the H-2 Complex to 
Inhibit lg Complex Binding to Mouse B Lymphocytes 
Aggre-  Specificity of this  Surface  gated Ig 
Exp.  Strain  Antiserum  combination  Ig  binding 
A 
B 
% Positive 
A.TL  Normal A/J  --  55.0  53.5 
A/J Anti-A.SW  K region of H-2 complex  >99.5  54.0 
B 10 anti-B 10.A  H-2 complex except  > 99.5  6.5 
K region 
A.SW  Normal A/J  --  48.0  48.5 
A/J anti-A.SW  Whole 11-2 complex  >99.5  8.0 
B10.A(2R)  Normal B10.A  --  49.0  50.5 
B10.A anti-B10*  D region of H-2 complex  81.0  49.0 
B10 anti-B10.A  H-2 complex except  >99.5  12.5 
D region 
B10.A(4R)  Normal B10.A  --  50.5  53,0 
B10.A anti-B10  All regions of H-2  96.0  48.5 
complex except K 
and Irl 
B10 anti-B10,A  K and Irl regions of  >99.5  10.5 
H-2 complex 
B 10  Normal B 10.A  --  46.5  47.0 
B10.A anti-B10  Whole H-2 complex  94.5  5.0 
* Because of the poor response of B10.A mice to the D region specificities of B10 (24) this 
serum, even when undiluted, was not on the plateau of cytotoxic activity. This probably ex- 
plains the incomplete staining observed with FIRAMIG in this case. However,  other anti- 
H-2 and anti-Ia antisera produced marked inhibition of Ig complex binding at similar points 
on their cy  totoxic titration curves, indicating that the failure to obtain blocking in this instance 
was significant. 
Ig complex binding or be inhibited in their ability to bind aggregates, respec- 
tively, when used in the appropriate combinations. 
The  experiment  with  lymphocytes  from  B10.A(4R)  mice  was  particularly 
interesting since, when  using antiserum  B10.A  anti-B10,  one might  expect to 
detect antibodies against antigens determined by the Ir-IgG region (25).  Since 
there  is  evidence  that  this  region does  determine  some  Ia  antigens  (9),  this 
result suggests a  possible deletion of Ia antigen(s)  in the Ir-IgG region of the 
B10.A(4R), as has previously been proposed (13). 
Further  evidence  for  a  lack of  relationship between  H-2  K  and  D  region 
specificities and  the  Fc  receptor  was  obtained  by  testing  mouse  lymphoma 
cells  of  T-cell  origin  (EL4  and  RDM  4).  These  tumor  cells  expressed  H-2 
antigens but not Ia antigens as determined by direct cytotoxicity and absorp- 
tion of cytotoxic activity,  2 and did not bind Ig complexes. The  results of this 
section provided strong evidence for the lack of a  relationship between antigens 
determined  by  the  K  or D  regions of the  H-2  complex and  the  Fc receptor, 790  THE  FC  RECEPTOR  AND  Ia  ALLOANTIGENS 
and thus indicated the necessity of anti-Ia activity to produce the inhibition 
of binding of Ig complexes to B lymphocytes. 
Codominant Expression of Ia A lloantigen.--The  apparent existence of numer- 
ous Ia antigens  (7-11, footnote 2)  raised  the question of whether B-cell allo- 
antigens determined by different genes were expressed on all B lymphocytes or 
on  different  B  lymphocytes  (e.g.  allelic  exclusion)  within  the  same  strain. 
Therefore, (B6A)FI lymphocytes were incubated with reciprocal antisera, each 
of which  recognized the  Ia antigens  of one parent but not  the other (B10.A 
anti-B10 and B10 anti-B10.A), and then assayed for aggregate binding (Table 
X). It was expected that if allelic exclusion occurred in this system only about 
half of the B lymphocytes would be inhibited in their ability to bind Ig com- 
plexes, whereas if all B lymphocytes bore the Ia antigens of each parent, then 
no inhibition would be seen (since approximately half of the Ia antigens of each 
B cell would not be recognized by antibody). Surprisingly, each of the antisera 
produced  marked  inhibition  of  Ig  complex binding  to  the  F1  lymphocytes. 
That this was not due to shedding of antigen-antibody complexes was shown 
by the  control experiment using  a  mixture of B10  and  B10.A  lymphocytes, 
where, as expected, only partial inhibition was caused by each antiserum. Thus, 
it was apparent that most, if not all, of the B lymphocytes expressed at least 
certain of the Ia antigens separately inherited from each parent. However, the 
results did not rule out allelic exclusion of individual Ia specificities since each 
of  the  reciprocal  antisera  recognize multiple  Ia  antigens?  The  reason  why 
marked inhibition (instead of no inhibition) was obtained was less  clear. The 
most trivial explanation would be that if some Fc receptors are inhibited, then 
the rest cannot be detected because of the relative insensitivity of the direct 
fluorescent  technique.  A  second  possibility  would  be  that  distinct  parental 
genes determined different portions of the same molecule. There is some chemi- 
cal evidence to contradict this explanation (15).  Finally, Ia antigens may be 
clustered on the cell surface such that antibodies reactive with some serve to 
block all.  Experiments are in progress to differentiate between these possibili- 
ties. 
TABLE  X 
Codomlnant Expression  of Parental Ia Alloantigens on B  Lymphocytes from  (B6A)FI  Mice 
Surface  Aggre-  Strain  Antiserum  Ig  gated Ig 
binding 
(B6A) FI 
Mixture (1/] B10 +  1/~ B10.A) 
% Positive 
Normal B10.A  58.0  57.5 
B10.A anti-B10  92.5  9.5 
B10 anti-B 10.A  99.5  7.5 
Normal B 10.A  59.5  57.0 
B10.A anti-B 10  78.5  41.5 
B10 anti-B 10.A  80.0  39.0 HOWARD  B.  DICKLER  AND  DAVID  H.  SACHS  791 
DISCUSSION 
Immunoglobulin  complexes, composed of  FI-Agg  have  been  shown  in  the 
present studies  to  bind to mouse  B  lymphocytes of a  variety of strains,  but 
not to either thymocytes or thymus-derived (non-Ig bearing)  spleen lympho- 
cytes under a variety of conditions. Results with this assay confirm most pre- 
vious studies of the binding of Ig complexes to mouse lymphocytes (1,  2, 5, 6), 
and offer the advantages of being both simple and rapid. Further, the binding 
of Agg complexes was shown not to be due to either natural human antibodies 
against mouse antigens nor nonspecific binding of human Ig by mouse lympho- 
cytes.  Such  complexes were  also  shown  to  bind  to  the  same  sites  as  mouse 
antibody-antigen complexes. There is much evidence that Ig complexes (either 
heat-aggregated or antigen-antibody) require an intact Fc in order to bind to 
lymphocytes (2, 4, 5, 22), and the binding site has been termed the Fc receptor. 
These results of aggregate binding to mouse lymphocytes differ from those 
of Anderson and Grey (22), who found that aggregated Ig bound not only to 
B  lymphocytes but also to some thymocytes and  thymus-derived spleen lym- 
phocytes. This discrepancy might be accounted for by differences in sensitivity 
of the assays used, or by differences in the source of Ig used for heat aggrega- 
tion. The radioautographic assay employed by those workers may have been 
more sensitive than the present fluorescent system, thereby allowing detection 
of receptors on T  cells. The second difference, potentially more important, was 
that  they used mouse myeloma proteins. In  a  single experiment (Table II in 
Ref. 22)  they found that  aggregates of human Ig bound as well  as mouse Ig 
to mouse spleen lymphocytes (40% vs.  38%  respectively), while in  contrast 
human  Ig  aggregates  showed little binding  to  mouse  thymocytes (similar  to 
the present study). Thus, the receptor for Ig complexes on T  cells may differ 
in specificity from the Fc receptor of B  cells.  The inhibition studies  reported 
here apply only to the Fc receptor of B lymphocytes. 
The present studies have shown that anti-H-2 antisera are able to markedly 
inhibit the binding of Ig complexes to B lymphocytes. A series of experiments 
indicated  that  this inhibition was not due  to  the artifact of shedding of H-2 
antibody-antigen complexes, nor to  nonspecific steric inhibition.  Further  ex- 
periments  showed  that  the  antibodies  within  anti-H-2  antisera  which  were 
responsible for this inhibition were specific for alloantigens associated with the 
Ir region. Antisera specific for these Ia antigens produced inhibition  whereas 
antisera  specific for antigens  determined by  the  K  or  D  regions  of  the H-2 
complex did not.  Finally, evidence was obtained that Ia antigens are codomi- 
nantly  expressed  on  every B  lymphocyte. These  data  indicate  that  the  Fc 
receptor and  a  series  of alloantigens  controlled by  the  Ir  region  of  the  H-2 
complex are identical or closely associated on the B-lymphocyte surface mem- 
brane. 
Proof that the Fc receptor and Ia antigens are identical (as opposed to a close physi- 
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the report by Vitetta, et al.  (16), using lymphocyte solubilization  techniques,  of  the 
isolation  of Ia antigens via immunoprecipitation. These authors noted in their discus- 
sion that: "... immune complexes formed with control sera (including NMS) appeared 
to bind a  portion of Ia molecules.",  and  that:  "analyses by acrylamide gel electro- 
phoresis of the reduced  immunoprecipitates obtained with RAMIG disclosed an addi- 
tional peak of radioactivity that migrated like Ia." These observations, although not 
interpreted by the authors, may indicate chemical  identity between the Fc receptor 
and Ia antigens. 
Little is presently known of the functional  significance of either the Fc receptor or 
the Ia antigens in the immune response. Further, despite their similar genetic localiza- 
tion, the relationship between genes determining Ia antigens and genes controlling  im- 
mune responsiveness to many immunogens  (Ir genes) (26) is unclear. It is also unknown 
whether there are different Fc receptors with different  specificities on B lymphocytes, 
although there is some evidence consistent with this possibility (4). If such different  Fc 
receptor specificities exist,  they may correlate with the different serologically  defined 
specificities of Ia antigens. In any case, the identity or close association  between a recep- 
tor for antibody and a series of alloantigens  determined by the Ir region  of the  H-2 
complex is intriguing  and raises the possibility that Fc receptor/Ia antigens play a role 
in control of the immune response. 
Most  immunogens  for  which  genetic  control  of  the  immune  response  has 
been demonstrated are thymus-dependent, with cooperation between T  and B 
cells being required  for efficient antibody response  (26).  Also,  it has  recently 
been shown for several thymus-dependent antigens  that  the  "help" provided 
by T  ceils can be replaced by factors derived from antigen-stimulated activated 
T  cells  (27-29).  Such  factors are antigen  specific, but  there is conflicting evi- 
dence as  to  their biochemical nature  (27,  29).  Finally,  evidence has been ob- 
tained  that  in  certain  cases of Ir gene  control,  the  defect  in  low  responders 
appears to be expressed at the level of the B cell  (29-32). It has been proposed 
that  such  unresponsiveness at  the  B-cell level is  to  the haptenic determinant 
rather than the carrier portion of the immunogen (33). Thus, it is possible that 
cooperation between T  and  B  cells requires a  receptor site on the  B  lympho- 
cyte  which  recognizes  either T  cells  or  an  antigen-specific T-cell  factor.  We 
wish  to propose  that  this  receptor is  Fc  receptor/Ia  antigens.  The proposed 
interaction between a T-cell factor and Fc receptor/Ia antigens might provide 
the second signal hypothesized by the Bretcher-Cohn model for B-cell activa- 
tion  (34). 
The  B-lymphocyte Fc  receptor has  clearly demonstrated  capacity to  bind 
complexed  antibody.  However,  the  antigen-specific T-cell  helper factor need 
not  be immunoglobulin. It seems possible that  this T-cell factor might either 
contain antibody or, alternatively, a product of the Ir genes which may or may 
not have structural similarity to the Fc portion of complexed Ig. In either case 
the specificity of the Fc receptor/Ia antigens for complexed Ig might serve as 
a  means for regulation of the immune response by feed-back inhibition due to 
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In addition to B lymphocytes, there is much evidence that other cell types 
can also bind immunoglobulin, including some T  lymphocytes (22), activated 
T  lymphocytes (22, 36, 37), monocytes and macrophages (38, 39), and basophils 
(40).  The present  observations  raise  the  question of whether the  Ig-binding 
site(s) of these other cell types may also be associated with Ia antigens. If this 
were the  case, it is possible  to envision a  relationship between Ir genes and 
several diverse aspects of the immune response including the ability of T  cells 
to bind antigen via cytophilic antibody (41), the ability of antibody to augment 
the helper effect of activated T  cells (42), the ability of antibody to stimulate 
phagocytosis in  macrophages  (43),  and  the  antigen-triggered  IgE-dependent 
release of mediators from basophils (44). 
SUMMARY 
Immunoglobulin  complexes, composed of heat-aggregated human  Ig,  were 
shown  to  bind  to  mouse  B  lymphocytes of a  variety of strains,  but  not  to 
either thymocytes or thymus-derived (T) lymphocytes under a variety of con- 
ditions. It was shown that this binding was not due to either natural human 
antibodies  against  mouse  nor to nonspecific binding  of human  Ig by mouse 
lymphocytes. Such complexes were shown to bind to the same sites which bind 
mouse antibody-antigen complexes. This site is known as the Fc receptor. 
The binding of Ig complexes to mouse B lymphocytes was markedly inhibited 
by pretreatment of the lymphocytes with anti-H-2 antisera. A series of experi- 
ments indicated the specificity of this result, including the fact that this inhi- 
bition was shown not to be due to the artifact of shedding of H-2 antibody- 
antigen complexes, nor to nonspecific steric inhibition. 
The  antibodies  within  anti-/-/-2  antisera  which  were  responsible  for  this 
inhibition were specific for alloantigens  associated  with  the  Ir  region of the 
/-/-2 complex (Ia antigens). Antiserum specific for these Ia antigens produced 
inhibition,  whereas  antisera specific for antigens  determined by the  K  or D 
regions of the H-2 complex did not.  Evidence was  obtained using  F~ hybrid 
cells that  at  least  some Ia antigens  of both parental  types are  expressed on 
every B lymphocyte (i.e. codominant expression). 
These data indicate that  the  Fc  receptor and  a  series of alloantigens  con- 
trolled by the Ir region of the H-2 complex are identical or closely associated 
on the B-lymphocyte surface membrane. This observation may have implica- 
tions for the mechanism of control of the immune response. 
Grateful acknowledgement is  made to M.  Kubicek  and J. L. Cone  for  invaluable assis- 
tance, and to Dr.  W. D. Terry for helpful discussions. 
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